Acadia Pharmaceuticals reported $-45574000 in EBITDA for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acadia Pharmaceuticals ACAD:US USD -45574000 15.21M
Alnylam Pharmaceuticals ALNY:US USD -174303000 73.14M
Aptinyx Inc APTX:US USD -14557000 2.45M
Biogen BIIB:US USD 998.8M 6M
Biomarin Pharmaceutical BMRN:US USD 53K 22.33M
Bristol Myers Squibb BMY:US USD 4.66B 663M
Cara Therapeutics CARA:US USD -31246000 7.46M
Corcept Therapeutics CORT:US USD 22.68M 9.45M
Cytokinetics CYTK:US USD -125372000 18.34M
Eisai 4523:JP JPY 18.72B 11.02B
Intercept Pharmaceuticals ICPT:US USD -17884000 7.82M
Intra Cellular Therapies ITCI:US USD -47225000 8.23M
Johnson & Johnson JNJ:US USD 7.34B 1.2B
Marinus Pharmaceuticals MRNS:US USD -29130000 811K
Moderna Inc MRNA:US USD 1.66B 381M
Neurocrine Biosciences NBIX:US USD 107.8M 16M
Pfizer PFE:US USD 6.94B 3.94B
Prothena PRTA:US USD 128K 50.26M
Ptc Therapeutics PTCT:US USD -128092000 94.38M
Sarepta Therapeutics SRPT:US USD -96280000 24.37M
Seattle Genetics SGEN:US USD -136103000 39.11M
Ultragenyx Pharmaceutical RARE:US USD -140671000 79.7M
Vanda Pharmaceuticals VNDA:US USD 7.29M 2.71M
YTE INCY:US USD 111.58M 23.37M